Answers are grounded in this paper and cite their sources.
Treatment of JIA with etanercept may be associated with a wide spectrum of severe side effects. Although most patients initially respond to etanercept, this initial response is not always followed by sustained improvement over longer periods of time. In addition, the higher rate of treatment failure in the group with systemic-onset JIA indicates that these patients in particular may require alternative treatments.
No takes yet. Share an insight, caveat, or question.
Quartier et al. (2003) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: